CMMB news · CMMB stock

CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza

Yahoo Finance · Oct 10, 2025 · Chemomab Therapeutics Ltd DRC (CMMB)

Cidara Therapeutics wins FDA Breakthrough Therapy tag for CD388 for the prevention of seasonal influenza. Stock rises.

Original at Yahoo Finance

Not investment advice. Cached headline, not a full reprint.